Detalhe da pesquisa
1.
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS).
Gynecol Oncol
; 156(1): 45-53, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836184
2.
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Ann Oncol
; 29(3): 737-743, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29267856
3.
Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.
Ann Oncol
; 28(8): 1849-1855, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28595285
4.
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.
Ann Oncol
; 28(4): 702-710, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28119296
5.
Neoadjuvant chemotherapy in ovarian cancer revisited.
Ann Oncol
; 27 Suppl 1: i30-i32, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141067
6.
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
Ann Oncol
; 27(8): 1505-10, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27407100
7.
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
Ann Oncol
; 27(9): 1733-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287207
8.
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol
; 27(12): 2236-2241, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789470
9.
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Br J Cancer
; 112(4): 660-6, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562434
10.
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Ann Oncol
; 25(7): 1320-1327, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24618151
11.
Surgical intervention in relapsed ovarian cancer is beneficial: pro.
Ann Oncol
; 24 Suppl 10: x33-34, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265400
12.
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy.
Ann Oncol
; 23(9): 2265-2271, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377563
13.
Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients.
ESMO Open
; 6(2): 100081, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743329
14.
[Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results]. / Peritoneal metastasiertes Ovarialkarzinom. Vorgehensweise und Behandlungsergebnisse.
Chirurg
; 78(12): 1111-6, 2007 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-17994201
15.
[Epithelial ovarian cancer]. / Das epitheliale Ovarialkarzinom.
Ther Umsch
; 64(7): 375-80, 2007 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-17948754
16.
Corrigendum to 'Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients': [ESMO Open Volume 6, Issue 2, April 2021, 100081].
ESMO Open
; 6(4): 100176, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474812
17.
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
Eur J Cancer
; 66: 114-24, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561452
18.
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer.
Geburtshilfe Frauenheilkd
; 76(2): 147-149, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941446
19.
Sexual activity as cause for non-surgical pneumoperitoneum.
JSLS
; 4(4): 297-300, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11051188
20.
[Non-cardiogenic pulmonary edema associated with severe diabetic ketoacidosis]. / Oedema pulmonaire non cardiogénique associé à une acidocétose diabétique sévère.
Ann Fr Anesth Reanim
; 6(2): 127-8, 1987.
Artigo
em Francês
| MEDLINE | ID: mdl-3109284